A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus
Clinical trial NCT04493541 · COMPLETED
Trial details
- NCT number
- NCT04493541
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2023-04-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.